205 related articles for article (PubMed ID: 18519771)
21. Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial.
Ogino S; Liao X; Imamura Y; Yamauchi M; McCleary NJ; Ng K; Niedzwiecki D; Saltz LB; Mayer RJ; Whittom R; Hantel A; Benson AB; Mowat RB; Spiegelman D; Goldberg RM; Bertagnolli MM; Meyerhardt JA; Fuchs CS;
J Natl Cancer Inst; 2013 Dec; 105(23):1789-98. PubMed ID: 24231454
[TBL] [Abstract][Full Text] [Related]
22. DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.
Sinicrope FA; Foster NR; Thibodeau SN; Marsoni S; Monges G; Labianca R; Kim GP; Yothers G; Allegra C; Moore MJ; Gallinger S; Sargent DJ
J Natl Cancer Inst; 2011 Jun; 103(11):863-75. PubMed ID: 21597022
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy.
Czajka-Francuz P; Prendes MJ; Mankan A; Quintana Á; Pabla S; Ramkissoon S; Jensen TJ; Peiró S; Severson EA; Achyut BR; Vidal L; Poelman M; Saini KS
Front Oncol; 2023; 13():1200646. PubMed ID: 37427115
[TBL] [Abstract][Full Text] [Related]
24. Colorectal cancer in patients of advanced age is associated with increased incidence of
Christenson ES; Tsai HL; Le DT; Jaffee EM; Dudley J; Xian RR; Gocke CD; Eshleman JR; Lin MT
Front Oncol; 2023; 13():1193259. PubMed ID: 37350948
[TBL] [Abstract][Full Text] [Related]
25. Microsatellite Status Detection of Colorectal Cancer: Evaluation of Inconsistency between PCR and IHC.
Chen J; Yan Q; Sun J; Wang Q; Tao Y; Xiao D; Xie B
J Cancer; 2023; 14(7):1132-1140. PubMed ID: 37215453
[No Abstract] [Full Text] [Related]
26. Prognostic Significance of MRE11 Overexpression in Colorectal Cancer Patients.
Ho V; Chung L; Wilkinson K; Lea V; Lim SH; Abubakar A; Ng W; Lee M; Roberts TL; Chua W; Lee CS
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173905
[TBL] [Abstract][Full Text] [Related]
27. BRAF
Ma Z; Qi Z; Gu C; Yang Z; Ding Y; Zhou Y; Wang W; Zou Q
Am J Cancer Res; 2023; 13(4):1486-1497. PubMed ID: 37168352
[TBL] [Abstract][Full Text] [Related]
28. Emerging evidence of immunotherapy for colorectal cancer.
Miyamoto Y; Ogawa K; Ohuchi M; Tokunaga R; Baba H
Ann Gastroenterol Surg; 2023 Mar; 7(2):216-224. PubMed ID: 36998297
[TBL] [Abstract][Full Text] [Related]
29. Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: a multicenter retrospective study.
Meng Q; Zhao J; Yu Y; Wang K; Ren J; Xu C; Wang Y; Wang G
BMC Cancer; 2023 Feb; 23(1):191. PubMed ID: 36849918
[TBL] [Abstract][Full Text] [Related]
30. Traditional Chinese medicine for colorectal cancer treatment: potential targets and mechanisms of action.
Chen JF; Wu SW; Shi ZM; Hu B
Chin Med; 2023 Feb; 18(1):14. PubMed ID: 36782251
[TBL] [Abstract][Full Text] [Related]
31. Microsatellite instability and chemosensitivity in solid tumours.
Cherri S; Oneda E; Noventa S; Melocchi L; Zaniboni A
Ther Adv Med Oncol; 2022; 14():17588359221099347. PubMed ID: 35620236
[TBL] [Abstract][Full Text] [Related]
32. BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective.
Yan N; Guo S; Zhang H; Zhang Z; Shen S; Li X
Front Oncol; 2022; 12():863043. PubMed ID: 35433454
[TBL] [Abstract][Full Text] [Related]
33. Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer.
Zhou H; Zhu L; Song J; Wang G; Li P; Li W; Luo P; Sun X; Wu J; Liu Y; Zhu S; Zhang Y
Mol Cancer; 2022 Mar; 21(1):86. PubMed ID: 35337361
[TBL] [Abstract][Full Text] [Related]
34. Current Perspectives on the Importance of Pathological Features in Prognostication and Guidance of Adjuvant Chemotherapy in Colon Cancer.
Chen K; Wang H; Collins G; Hollands E; Law IYJ; Toh JWT
Curr Oncol; 2022 Feb; 29(3):1370-1389. PubMed ID: 35323316
[TBL] [Abstract][Full Text] [Related]
35. Microsatellite Status and IκBα Expression Levels Predict Sensitivity to Pharmaceutical Curcumin in Colorectal Cancer Cells.
Lu L; Przybylla R; Shang Y; Dai M; Krohn M; Krämer OH; Mullins CS; Linnebacher M
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205780
[TBL] [Abstract][Full Text] [Related]
36. Pathological Features and Prognostication in Colorectal Cancer.
Chen K; Collins G; Wang H; Toh JWT
Curr Oncol; 2021 Dec; 28(6):5356-5383. PubMed ID: 34940086
[TBL] [Abstract][Full Text] [Related]
37. Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes.
Wu W; Liu Y; Zeng S; Han Y; Shen H
J Hematol Oncol; 2021 Oct; 14(1):160. PubMed ID: 34620200
[TBL] [Abstract][Full Text] [Related]
38. Personalized Therapy and Liquid Biopsy-A Focus on Colorectal Cancer.
Christou N; Veyrune L; Popeskou SG; Mathonnet M
J Pers Med; 2021 Jul; 11(7):. PubMed ID: 34357097
[TBL] [Abstract][Full Text] [Related]
39. Microsatellite Instability in Sporadic Colorectal Malignancy: A Pilot Study from Northern India.
Chauhan S; Kumar S; Singh P; Husain N; Masood S
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2279-2288. PubMed ID: 34319053
[TBL] [Abstract][Full Text] [Related]
40. Precision oncology in metastatic colorectal cancer - from biology to medicine.
Di Nicolantonio F; Vitiello PP; Marsoni S; Siena S; Tabernero J; Trusolino L; Bernards R; Bardelli A
Nat Rev Clin Oncol; 2021 Aug; 18(8):506-525. PubMed ID: 33864051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
